PLEKHB2 and breast cancer: Of clinical relevance is our finding that the PS-flippase and evectin-2/Nedd4 E3 ligase were active in an aggressive metastatic breast cancer cell line, which could lead to new drug targets for cancers in which the malignancy depends on YAP function.